Atlas Trials

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Clinical trial NCT02764229 · TERMINATED

Trial details

NCT number
NCT02764229
Sponsor
Lycera Corp.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2016-11-01
Primary completion
2018-07-18
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.